Neurothera Labs Inc. (TSXV: NTLX)
Health Care · Pharmaceuticals · US
CA$4.40
+0.23% today · +57.1% 1Y
Neurothera Labs Inc. (TSXV: NTLX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $42.38M.
Over the last twelve months the share price has gained 57.1%, trading between 2.17 and 5.32.
Tweenvest scores Neurothera Labs Inc. across four factors: quality 44/100, value 45/100. Its strongest factor is value.
NTLX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $42.38M
- Revenue (TTM)
- $680.00K
- P/E
- —
- EPS
- -0.88
- Dividend yield
- —
- Beta (5Y)
- -0.02
- 52-week high
- CA$5.32
- 52-week low
- CA$2.17
- Avg volume (3M)
- —
- Shares outstanding
- 13.72M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Veru Inc.NasdaqCM: VERU | $42.80M | $2.42 | -3.59% |
| Hayat Pharmaceutical Industries Co. PLCASE: HPIC | $42.77M | JD3.19 | +1.27% |
| Orion Infusion LimitedDSE: ORIONINFU | $42.63M | Tk257.70 | -1.98% |
| Jenburkt Pharmaceuticals LimitedBSE: 524731 | $42.42M | Rs925.40 | -2.43% |
| Herantis Pharma OyjHLSE: HRTIS | $42.30M | €1.42 | +1.29% |
| ADBiotech Co., Ltd.KOSDAQ: A179530 | $41.12M | ₩2,055.00 | +17.16% |
| Tsubota Laboratory IncorporatedTSE: 4890 | $41.05M | ¥251.00 | -2.33% |
| Incannex Healthcare Inc.NasdaqCM: IXHL | $40.14M | $3.20 | +0.63% |
Figures last refreshed Oct 4, 2026.